Siemens Healthineers Receives $83 Million to Advance Cancer Radiation Technology
The five-year project funded by ARPA-H aims to develop ultra-high dose rate photon therapy for standard linear accelerators.
The five-year project funded by ARPA-H aims to develop ultra-high dose rate photon therapy for standard linear accelerators.
As part of a deal inked earlier this year, Varian Medical Systems is deploying its linear accelerators throughout the nation of Turkey. Under the company’s partnership with the Turkish Ministry of Health, Varian will install 14 of its Clinac iX and Trilogy systems at public radiotherapy centers across the country.
The five-year project funded by ARPA-H aims to develop ultra-high dose rate photon therapy for standard linear accelerators.